Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error

被引：0

作者：

M Shipitsin

C Small

S Choudhury

E Giladi

S Friedlander

J Nardone

S Hussain

A D Hurley

C Ernst

Y E Huang

H Chang

T P Nifong

D L Rimm

J Dunyak

M Loda

D M Berman

P Blume-Jensen

机构：

[1] Metamark Genetics Inc.,Department of Pathology

[2] Yale University Medical School,Department of Pathology

[3] Dana Farber Cancer Institute,Department of Pathology and Molecular Medicine and Queen’s Cancer Research Institute

[4] Harvard Medical School,undefined

[5] Queen’s University,undefined

[6] Present address: Karyopharm Therapeutics,undefined

[7] Natick,undefined

[8] MA 01760,undefined

[9] USA.,undefined

来源：

British Journal of Cancer | 2014年 / 111卷

关键词：

prostate cancer; biopsy; biomarkers; prognosis; sampling error; tumour heterogeneity;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1201 / 1212

页数：11

共 29 条

[1] Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
Shipitsin, M.
Small, C.
Choudhury, S.
Giladi, E.
Friedlander, S.
Nardone, J.
Hussain, S.
Hurley, A. D.
Ernst, C.
Huang, Y. E.
Chang, H.
Nifong, T. P.
Rimm, D. L.
Dunyak, J.
Loda, M.
Berman, D. M.
Blume-Jensen, P.
BRITISH JOURNAL OF CANCER, 2014, 111 (06) : 1201 - 1212
[2] Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis
Lin, Jian-Feng
Xu, Jun
Tian, Hong-Yu
Gao, Xia
Chen, Qing-Xi
Gu, Qi
Xu, Gen-Jun
Song, Jian-Da
Zhao, Fu-Kun
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (12) : 2596 - 2605
[3] Mitochondria, Prostate Cancer, and Biopsy Sampling Error
Parr, Ryan
Mills, John
Harbottle, Andrew
Creed, Jennifer
Crewdson, Gregory
Reguly, Brian
Guimont, Francois
DISCOVERY MEDICINE, 2013, 15 (83) : 213 - 220
[4] Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?
Francesca Carozzi
Lara Tamburrino
Simonetta Bisanzi
Sara Marchiani
Milena Paglierani
Simonetta Di Lollo
Emanuele Crocetti
Carlotta Buzzoni
Elena Burroni
Luana Greco
Elisabetta Baldi
Cristina Sani
Journal of Cancer Research and Clinical Oncology, 2016, 142 : 201 - 212
[5] Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?
Carozzi, Francesca
Tamburrino, Lara
Bisanzi, Simonetta
Marchiani, Sara
Paglierani, Milena
Di Lollo, Simonetta
Crocetti, Emanuele
Buzzoni, Carlotta
Burroni, Elena
Greco, Luana
Baldi, Elisabetta
Sani, Cristina
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (01) : 201 - 212
[6] Identification of MicroRNAs as Viable Aggressiveness Biomarkers for Prostate Cancer
Martinez-Gonzalez, Luis Javier
Sanchez-Conde, Victor
Gonzalez-Cabezuelo, Jose Maria
Antunez-Rodriguez, Alba
Andres-Leon, Eduardo
Robles-Fernandez, Inmaculada
Lorente, Jose Antonio
Vazquez-Alonso, Fernando
Alvarez-Cubero, Maria Jesus
BIOMEDICINES, 2021, 9 (06)
[7] PROSTATE CANCER Predicting tumor aggressiveness using DWI-guided biopsy
Kim, Chan Kyo
Takahashi, Satoru
NATURE REVIEWS UROLOGY, 2011, 8 (12) : 652 - 654
[8] Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: A review
Downes, M. R.
Byrne, J. C.
Dunn, M. J.
Fitzpatrick, J. M.
Watson, R. W. G.
Pennington, S. R.
BIOMARKERS, 2006, 11 (05) : 406 - 416
[9] Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer
Duijvesz, Diederick
Burnum-Johnson, Kristin E.
Gritsenko, Marina A.
Hoogland, A. Marije
Vredenbregt-van den Berg, Mirella S.
Willemsen, Rob
Luider, Theo
Pasa-Tolic, Ljiljana
Jenster, Guido
PLOS ONE, 2013, 8 (12):
[10] Predicting Prostate Cancer Biochemical Recurrence Using a Panel of Serum Proteomic Biomarkers
Rosenzweig, C. Nicole
Zhang, Zhen
Sun, Xiaer
Sokoll, Lori J.
Osborne, Katherine
Partin, Alan W.
Chan, Daniel W.
JOURNAL OF UROLOGY, 2009, 181 (03): : 1407 - 1414

← 1 2 3 →